In addition, leptin replacement promotes disease regression in animal models of advanced diabetic nephropathy by increasing podocyte number, another effect that may reasonably be mediated by podocyte regeneration provided by RPCs (Pichaiwong et al., 2013). The gene discussed is LEP; the disease is diabetic kidney disease.